Baker Mark Robert
Insider CIK 1331438 · PGNX Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2019-03-01 | 2019-03-05 | 192,500 | — | $0 | 192,500 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2018-03-01 | 2018-03-02 | 201,250 | — | $0 | 201,250 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2017-03-01 | 2017-03-07 | 175,000 | — | $0 | 175,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2016-03-01 | 2016-03-03 | 175,000 | $4.52 | $791.0K | 175,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2015-03-02 | 2015-03-04 | 132,000 | $6.65 | $877.8K | 132,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2014-03-03 | 2014-03-04 | 132,000 | $4.70 | $620.4K | 132,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2013-04-04 | 2013-04-08 | 120,000 | $5.03 | $603.6K | 120,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2013-03-27 | 2013-03-28 | 50 | $5.34 | $267 | 161,041 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2013-03-27 | 2013-03-28 | 100 | $5.36 | $536 | 161,141 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2013-03-27 | 2013-03-28 | 500 | $5.31 | $2.7K | 160,991 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2013-02-27 | 2013-02-28 | 227 | $2.75 | $624 | 160,491 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2013-02-27 | 2013-02-28 | 500 | $2.71 | $1.4K | 159,729 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2013-02-27 | 2013-02-28 | 535 | $2.72 | $1.5K | 160,264 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2013-01-22 | 2013-01-23 | 900 | $2.82 | $2.5K | 158,914 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2013-01-22 | 2013-01-23 | 315 | $2.83 | $891 | 159,229 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-12-26 | 2012-12-26 | 1,142 | $3.01 | $3.4K | 158,014 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-11-28 | 2012-11-30 | 100 | $2.13 | $213 | 155,765 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-11-28 | 2012-11-30 | 1,000 | $2.13 | $2.1K | 156,865 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-11-28 | 2012-11-30 | 100 | $2.13 | $213 | 155,865 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-11-28 | 2012-11-30 | 7 | $2.14 | $15 | 156,872 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-11-28 | 2012-11-30 | 100 | $2.12 | $212 | 155,665 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-11-28 | 2012-11-30 | 300 | $2.12 | $636 | 155,565 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-11-19 | 2012-11-20 | 11,800 | $1.96 | $23.1K | 155,265 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-11-16 | 2012-11-19 | 49,793 | $1.82 | $90.6K | 143,465 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-11-15 | 2012-11-16 | 48,833 | $1.69 | $82.5K | 93,672 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-10-24 | 2012-10-25 | 1,162 | $2.96 | $3.4K | 44,839 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-09-26 | 2012-09-27 | 1,036 | $3.32 | $3.4K | 43,677 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-08-22 | 2012-08-23 | 815 | $4.23 | $3.4K | 42,641 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-07-25 | 2012-07-26 | 346 | $10.04 | $3.5K | 41,826 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-06-27 | 2012-06-29 | 75 | $9.21 | $691 | 41,180 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-06-27 | 2012-06-29 | 179 | $9.29 | $1.7K | 41,380 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-06-27 | 2012-06-29 | 100 | $9.29 | $929 | 41,480 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-06-27 | 2012-06-29 | 21 | $9.27 | $195 | 41,201 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-05-23 | 2012-05-24 | 445 | $7.81 | $3.5K | 41,105 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-04-25 | 2012-04-27 | 100 | $9.92 | $992 | 40,660 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-04-25 | 2012-04-27 | 133 | $10.25 | $1.4K | 40,445 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-04-25 | 2012-04-27 | 15 | $10.25 | $154 | 40,460 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-04-25 | 2012-04-27 | 100 | $9.97 | $997 | 40,560 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-03-28 | 2012-03-29 | 100 | $10.00 | $1.0K | 40,172 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-03-28 | 2012-03-29 | 103 | $10.18 | $1.0K | 40,072 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-03-28 | 2012-03-29 | 140 | $10.19 | $1.4K | 40,312 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2012-03-01 | 2012-03-05 | 66,666 | $9.81 | $654.0K | 66,666 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2012-03-01 | 2012-03-05 | 33,334 | $9.81 | $327.0K | 100,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-02-22 | 2012-02-23 | 166 | $9.40 | $1.6K | 39,766 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-02-22 | 2012-02-23 | 100 | $9.40 | $940 | 39,866 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-02-22 | 2012-02-23 | 2 | $9.42 | $19 | 39,868 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-02-22 | 2012-02-23 | 1 | $9.54 | $10 | 39,969 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-02-22 | 2012-02-23 | 100 | $9.45 | $945 | 39,968 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-01-25 | 2012-01-26 | 4 | $9.50 | $38 | 39,307 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-01-25 | 2012-01-26 | 63 | $9.45 | $595 | 39,299 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-01-25 | 2012-01-26 | 100 | $9.56 | $956 | 39,600 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-01-25 | 2012-01-26 | 3 | $9.49 | $28 | 39,303 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-01-25 | 2012-01-26 | 1 | $9.45 | $9 | 39,300 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-01-25 | 2012-01-26 | 193 | $9.55 | $1.8K | 39,500 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-01-11 | 2012-01-12 | 200 | $8.87 | $1.8K | 39,236 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2012-01-11 | 2012-01-12 | 191 | $8.86 | $1.7K | 39,036 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2011-10-26 | 2012-01-12 | 1 | $6.53 | $7 | 37,680 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2011-10-26 | 2012-01-12 | 76 | $6.50 | $494 | 38,211 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2011-10-26 | 2012-01-12 | 455 | $6.52 | $3.0K | 38,135 | SEC↗ |